Monitor for future announcements of actual share sales under this ATM program, as those will have a direct impact on share count and potential stock price pressure. The mere establishment of the facility is a routine capital markets tool and not an immediate catalyst.
Price Chart
Executive Summary
Regencell Bioscience Holdings Ltd (RGC) has entered into a sales agreement with Univest Securities to establish an at-the-market (ATM) offering facility, allowing the company to sell up to $500 million in ordinary shares incrementally. This filing incorporates the sales agreement and related legal opinions into the company's existing shelf registration. The move provides RGC with flexible access to capital for working capital, capital expenditures, and potential strategic transactions.
Key Facts
- Regencell Bioscience Holdings Ltd (RGC) has entered into a sales agreement with Univest Securities for an at-the-market (ATM) offering facility.
- The company can sell up to $500 million in ordinary shares through this facility.
- Proceeds will be used for working capital, capital expenditures, and general corporate purposes, including potential strategic transactions.
- The offering allows for incremental capital raising based on market conditions with no obligation to sell any specific amount.
- This 6-K filing incorporates the sales agreement and related legal opinions into the company's existing shelf registration.
Financial Impact
Up to $500 million in potential dilution from the sale of ordinary shares
Risk Factors
- Potential share dilution if the company actively sells shares under the ATM program
- Market perception of equity issuance as a negative signal, especially if done at low prices
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-035953 |
| Document: ea028393601ex8-1.htm | 0001213900-26-035953 |
| Document: ea0283936-6k_regencell.htm | 0001213900-26-035953 |
| Document: 0001213900-26-035953-index-headers.html | 0001213900-26-035953 |
| Document: 0001213900-26-035953-index.html | 0001213900-26-035953 |
| Document: 0001213900-26-035953.txt | 0001213900-26-035953 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 19d ago | 20-F | $7.63 $7.35 | ▲ +3.67% | ▲ +4.27% | $6.76 (+11.40%) |
May 22, 2026 22w ago | 6-K | $25.80 $24.31 | ▲ +5.78% | ▲ +6.36% | $6.76 (+73.80%) |
May 19, 2026 22w ago | 424B5 | $27.39 $27.00 | ▲ +1.42% | ▲ +1.62% | $6.76 (+75.32%) |
May 19, 2026 22w ago | 6-K | $27.00 $27.39 | ▲ +1.44% | ▲ +0.40% | $6.76 (−74.96%) |
May 8, 2026 24w ago | 6-K | $27.33 $26.35 | ▲ +3.59% | ▲ +3.45% | $6.76 (+75.27%) |
Apr 17, 2026 27w ago | 6-K | $28.10 $28.40 | ▼ −1.07% | ▼ −1.72% | $6.76 (+75.94%) |
Mar 30, 2026 30w ago | 6-K | $23.33 $25.43 | ▲ +9.00% | ▲ +6.11% | $6.76 (−71.02%) |
Mar 30, 2026 30w ago | 6-K | $23.33 $25.43 | ▲ +9.00% | ▲ +6.11% | $6.76 (−71.02%) |
Mar 30, 2026 30w ago | 424B5 | $23.33 $25.43 | ▲ +9.00% | ▲ +6.11% | $6.76 (−71.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers